Poonawalla Fincorp sells controlling stake in housing finance arm to Singapore company for Rs 3,004 crore

July 26, 2023

The Cyrus Poonawalla Group, more known for its vaccine-making business under the Serum Institute, in a statement said the financial consideration of Rs 3,004 crore is excluding the tax outgoes. With this sale, Poonawalla Housing Finance will cease to be a subsidiary of Poonawalla Fincorp, and Perseus will be holding a controlling stake.

More To Explore

GR Infraprojects shares zoom 7% on bagging Rs 4,263 crore project from NHAI

Shares of GR Infraprojects rose by 6.9% as the company was selected for a Rs 4,263 crore project from NHAI, involving the construction and enhancement

March 17, 2025

Tata Motors shares jump over 1% as board considers Rs 2,000 crore NCD issuance

Tata Motors shares rose 1.5% after the company announced that its Board Committee will meet on March 19, 2025, to consider issuing non-convertible debentures worth

March 17, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003